Cargando…

Induction of APOBEC3B expression by chemotherapy drugs is mediated by DNA-PK directed activation of NF-κB

The mutagenic APOBEC3B (A3B) cytosine deaminase is frequently over-expressed in cancer and promotes tumour heterogeneity and therapy resistance. Hence, understanding the mechanisms that underlie A3B over-expression is important, especially for developing therapeutic approaches to reducing A3B levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Periyasamy, Manikandan, Singh, Anup K, Gemma, Carolina, Farzan, Raed, Allsopp, Rebecca C, Shaw, Jacqueline A, Charmsaz, Sara, Young, Leonie S, Cunnea, Paula, Coombes, R Charles, Győrffy, Balázs, Buluwela, Lakjaya, Ali, Simak
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7116738/ https://www.ncbi.nlm.nih.gov/pubmed/33323971 http://dx.doi.org/10.1038/s41388-020-01583-7

Ejemplares similares

p53 controls expression of the DNA deaminase APOBEC3B to limit its potential mutagenic activity in cancer cells
por: Periyasamy, Manikandan, et al.
Publicado: (2017)

APOBEC3B-Mediated Cytidine Deamination Is Required for Estrogen Receptor Action in Breast Cancer
por: Periyasamy, Manikandan, et al.
Publicado: (2015)

CDK7 inhibitors as anticancer drugs
por: Sava, Georgina P., et al.
Publicado: (2020)

miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts
por: Pellegrino, Loredana, et al.
Publicado: (2013)

ZNF366 is an estrogen receptor corepressor that acts through CtBP and histone deacetylases
por: Lopez-Garcia, Jorge, et al.
Publicado: (2006)

Genome engineering for estrogen receptor mutations reveals differential responses to anti-estrogens and new prognostic gene signatures for breast cancer
por: Harrod, Alison, et al.
Publicado: (2022)

Author Correction: The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation
por: Smith, Linda, et al.
Publicado: (2018)

The responses of cancer cells to PLK1 inhibitors reveal a novel protective role for p53 in maintaining centrosome separation
por: Smith, Linda, et al.
Publicado: (2017)

ABC-transporter upregulation mediates resistance to the CDK7 inhibitors THZ1 and ICEC0942
por: Sava, Georgina P., et al.
Publicado: (2019)

DHX9 interacts with APOBEC3B and attenuates the anti-HBV effect of APOBEC3B
por: Chen, Yanmeng, et al.
Publicado: (2020)

Induction of APOBEC3-mediated genomic damage in urothelium implicates BK polyomavirus (BKPyV) as a hit-and-run driver for bladder cancer
por: Baker, Simon C., et al.
Publicado: (2022)

APOBEC3B Is Co-Expressed with PKCα/NF-κB in Oral and Oropharyngeal Squamous Cell Carcinomas
por: Fanourakis, Galinos, et al.
Publicado: (2023)

DNA cytosine and methylcytosine deamination by APOBEC3B: enhancing methylcytosine deamination by engineering APOBEC3B
por: Fu, Yang, et al.
Publicado: (2015)

Control of APOBEC3B induction and cccDNA decay by NF-κB and miR-138-5p
por: Faure-Dupuy, Suzanne, et al.
Publicado: (2021)

Roles of APOBEC3A and APOBEC3B in Human Papillomavirus Infection and Disease Progression
por: Warren, Cody J., et al.
Publicado: (2017)

Associations between the single nucleotide polymorphisms of APOBEC3A, APOBEC3B and APOBEC3H, and chronic hepatitis B progression and hepatocellular carcinoma in a Chinese population
por: He, Xiuting, et al.
Publicado: (2019)

GATA3 and APOBEC3B are prognostic markers in adrenocortical carcinoma and APOBEC3B is directly transcriptionally regulated by GATA3
por: Gara, Sudheer Kumar, et al.
Publicado: (2020)

APOBEC3B reporter myeloma cell lines identify DNA damage response pathways leading to APOBEC3B expression
por: Yamazaki, Hiroyuki, et al.
Publicado: (2020)

APOBEC3A and APOBEC3B are potent inhibitors of LTR-retrotransposon function in human cells
por: Bogerd, Hal P., et al.
Publicado: (2006)

Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B
por: Shi, K., et al.
Publicado: (2016)

Association of a germline copy number polymorphism of APOBEC3A and APOBEC3B with burden of putative APOBEC-dependent mutations in breast cancer
por: Nik-Zainal, Serena, et al.
Publicado: (2014)

Involvement of APOBEC3B in mutation induction by irradiation
por: Saito, Yohei, et al.
Publicado: (2020)

Genetic inhibitors of APOBEC3B-induced mutagenesis
por: Mertz, Tony M., et al.
Publicado: (2023)

Differential impact of classical and non-canonical NF-κB pathway-related gene expression on the survival of breast cancer patients
por: Espinoza-Sánchez, Nancy Adriana, et al.
Publicado: (2019)

LRH-1 drives colon cancer cell growth by repressing the expression of the CDKN1A gene in a p53-dependent manner
por: Kramer, Holly B., et al.
Publicado: (2016)

DNA-PK: gatekeeper for IKKγ/NEMO nucleocytoplasmic shuttling in genotoxic stress-induced NF-kappaB activation
por: Medunjanin, Senad, et al.
Publicado: (2020)

An APOBEC3A hypermutation signature is distinguishable from the signature of background mutagenesis by APOBEC3B in human cancers
por: Chan, Kin, et al.
Publicado: (2015)

Exploring APOBEC3A and APOBEC3B substrate specificity and their role in HPV positive head and neck cancer
por: Papini, Christina, et al.
Publicado: (2022)

APOBEC3A/B deletion polymorphism and cancer risk
por: Gansmo, Liv B, et al.
Publicado: (2018)

APOBEC3B: Future direction of liver cancer research
por: Yang, Xingyue, et al.
Publicado: (2022)

The APOBEC3B cytidine deaminase is an adenovirus restriction factor
por: Lejeune, Noémie, et al.
Publicado: (2023)

Observation of the decay $\Xi^-_b \to pK^- K^-$
por: Mathad, Abhijit
Publicado: (2017)

Search for CP violation using triple product asymmetries in $\Lambda^{0}_{b}\to pK^{-}\pi^{+}\pi^{-}$, $\Lambda^{0}_{b}\to pK^{-}K^{+}K^{-}$ and $\Xi^{0}_{b}\to pK^{-}K^{-}\pi^{+}$ decays
por: Aaij, Roel, et al.
Publicado: (2018)

APOBEC3B and APOBEC mutational signature as potential predictive markers for immunotherapy response in non-small cell lung cancer
por: Wang, Shixiang, et al.
Publicado: (2018)

BE-FLARE: a fluorescent reporter of base editing activity reveals editing characteristics of APOBEC3A and APOBEC3B
por: Coelho, Matthew A., et al.
Publicado: (2018)

TLR2-mediated NF-κB signaling pathway is involved in PPV1-induced apoptosis in PK-15 cells
por: Xu, Menglong, et al.
Publicado: (2022)

B-Myb Induces APOBEC3B Expression Leading to Somatic Mutation in Multiple Cancers
por: Chou, Wen-Cheng, et al.
Publicado: (2017)

Massive APOBEC3 Editing of Hepatitis B Viral DNA in Cirrhosis
por: Vartanian, Jean-Pierre, et al.
Publicado: (2010)

APOBEC3B, a molecular driver of mutagenesis in human cancers
por: Zou, Jun, et al.
Publicado: (2017)

APOBEC3B expression and its prognostic potential in breast cancer
por: Mao, Yan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qgat68qf6tdp8d78bfaof7msek